Global Intrauterine Devices Market Size Study & Forecast, by Type (Hormonal IUD and Copper IUD) by Distribution Channel (Hospital and Gynecology Clinics) and Regional Forecasts 2025-2035

The Global Intrauterine Devices (IUDs) Market is valued at approximately USD 6.24 billion in 2024 and is projected to grow at a CAGR of 3.70% over the forecast period 2025-2035. Intrauterine devices are small, often T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. Available in hormonal and copper variations, these devices operate through distinct mechanisms, either releasing hormones to inhibit ovulation and thicken cervical mucus or utilizing copper to create an inhospitable environment for sperm. The growing demand for reliable and long-term contraceptive solutions, coupled with rising awareness of family planning and reproductive health, is driving market expansion globally. In addition, supportive healthcare policies, increasing investments in women’s health, and innovation in IUD design are further catalyzing adoption in both developed and emerging markets.

The adoption of IUDs has surged due to a growing emphasis on long-acting reversible contraceptives (LARCs), which provide effective birth control while requiring minimal ongoing maintenance. According to recent studies, over 160 million women worldwide use intrauterine devices, and this number is expected to rise steadily, reflecting an increased prioritization of reproductive health. Furthermore, advancements in hormonal formulations and the introduction of smaller, user-friendly devices are creating attractive opportunities for market growth. Nevertheless, challenges such as limited awareness in certain regions, procedural complications, and regulatory compliance requirements may temper growth during the forecast period of 2025-2035.

The detailed segments and sub-segments included in the report are:

By Type:
• Hormonal IUD
• Copper IUD

By Distribution Channel:
• Hospital
• Gynecology Clinics

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• RoE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Hormonal IUDs Expected to Dominate the Market

Hormonal IUDs are expected to hold the largest share of the global market, owing to their enhanced efficacy, reduced menstrual bleeding, and prolonged duration of action, which appeals to both patients and healthcare providers. Meanwhile, copper IUDs maintain steady demand due to their hormone-free profile and suitability for women who prefer non-hormonal contraceptive methods. This market scenario indicates a clear preference for hormonal options in terms of adoption, while copper devices continue to serve a significant niche segment driven by specific patient needs and medical considerations.

Hospitals Lead in Revenue Contribution

Among distribution channels, hospitals currently generate the highest revenue share, as they serve as the primary centers for device insertion and post-procedural care. Gynecology clinics, however, are increasingly becoming significant contributors due to growing outpatient services, convenience, and improved access to trained healthcare professionals. This dual trend portrays a market where hospitals dominate revenue generation, while clinics emerge as a rapidly growing segment supported by decentralized and patient-centric care models.

North America emerged as the dominant regional market in 2025, driven by high awareness regarding contraceptive options, robust healthcare infrastructure, and extensive reimbursement coverage. Europe follows closely with strong adoption facilitated by government initiatives and widespread availability of IUDs. Asia Pacific is anticipated to be the fastest-growing region during 2025-2035, supported by rising population, increasing reproductive health awareness, and expanding healthcare access in countries such as India, China, and Japan. Latin America and the Middle East & Africa are gradually witnessing increased adoption due to growing healthcare investments, improving access to gynecological care, and targeted family planning programs.

Major market players included in this report are:
• Bayer AG
• CooperSurgical, Inc.
• Teva Pharmaceutical Industries Ltd.
• Medtronic plc
• Shanghai Dahua Medical Apparatus Co., Ltd.
• Allergan (AbbVie Inc.)
• BD (Becton, Dickinson and Company)
• Hologic, Inc.
• Guangzhou Wondfo Biotech Co., Ltd.
• Laboratoires Théa
• DKT International
• Innova Medical Devices Pvt Ltd.
• Chongqing Xinghan Medical Technology Co., Ltd.
• Merit Medical Systems, Inc.
• Nanjing Saide Medical Device Co., Ltd.

Global Intrauterine Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more